These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 29096998)

  • 1. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
    van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
    Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
    Yu JJ; Agrón E; Clemons TE; Domalpally A; van Asten F; Keenan TD; Cukras C; Chew EY;
    Ophthalmology; 2019 Feb; 126(2):261-273. PubMed ID: 30142373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.
    Thee EF; Colijn JM; Cougnard-Grégoire A; Meester-Smoor MA; Verzijden T; Hoyng CB; Fauser S; Hense HW; Silva R; Creuzot-Garcher C; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
    Ophthalmology; 2022 Jul; 129(7):752-764. PubMed ID: 35240203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.
    Andreoli MT; Morrison MA; Kim BJ; Chen L; Adams SM; Miller JW; DeAngelis MM; Kim IK
    Am J Ophthalmol; 2009 Dec; 148(6):869-74. PubMed ID: 19796758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
    ; Papudesu C; Clemons TE; Agrón E; Chew EY
    Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Perifoveal Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration.
    Seddon JM; Dossett JP; Widjajahakim R; Rosner B
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4469-4478. PubMed ID: 31658355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration: Epidemiologic and Genetic Evidence from UK Biobank OCT Data.
    Zekavat SM; Sekimitsu S; Ye Y; Raghu V; Zhao H; Elze T; Segrè AV; Wiggs JL; Natarajan P; Del Priore L; Zebardast N; Wang JC
    Ophthalmology; 2022 Jun; 129(6):694-707. PubMed ID: 35149155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study.
    Farinha C; Barreto P; Coimbra R; Cachulo ML; Melo JB; Cunha-Vaz J; Lechanteur Y; Hoyng CB; Silva R
    Acta Ophthalmol; 2023 Mar; 101(2):185-199. PubMed ID: 36036675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration.
    Seddon JM; Gensler G; Rosner B
    Ophthalmology; 2010 Aug; 117(8):1560-6. PubMed ID: 20346514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.
    Seddon JM; Reynolds R; Rosner B
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):586-91. PubMed ID: 18936151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.
    Ersoy L; Schick T; de Graft D; Felsch M; Hoyng CB; den Hollander AI; Kirchhof B; Fauser S; Liakopoulos S
    Br J Ophthalmol; 2016 Aug; 100(8):1047-51. PubMed ID: 26614632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
    Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
    Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
    Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O
    Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study.
    Ryu E; Fridley BL; Tosakulwong N; Bailey KR; Edwards AO
    Mol Vis; 2010 Dec; 16():2811-21. PubMed ID: 21197116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
    Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci.
    Pappas CM; Zouache MA; Matthews S; Faust CD; Hageman JL; Williams BL; Richards BT; Hageman GS
    Hum Genomics; 2021 Sep; 15(1):60. PubMed ID: 34563268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.